(Q41643173)

6 October 2017

title

Cobicistat-boosted protease inhibitors in HIV-infected patients with mild to moderate renal impairment (English)

1 reference

6 October 2017

Cheryl K McDonald

1

1 reference

6 October 2017

Claudia Martorell

2

1 reference

6 October 2017

Moti Ramgopal

3

1 reference

6 October 2017

Francois Laplante

4

1 reference

6 October 2017

Martin Fisher

5

1 reference

6 October 2017

Frank A Post

6

1 reference

6 October 2017

Yapei Liu

7

1 reference

6 October 2017

Joanne Curley

8

1 reference

6 October 2017

Michael E Abram

9

1 reference

6 October 2017

Joseph Custodio

10

1 reference

6 October 2017

Hiba Graham

11

1 reference

6 October 2017

Martin S Rhee

12

1 reference

6 October 2017

Javier Szwarcberg

13

1 reference

6 October 2017

language of work or name

1 reference

1 November 2014

1 reference

6 October 2017

1 reference

6 October 2017

volume

15

1 reference

6 October 2017

issue

6

1 reference

6 October 2017

page(s)

269-273

1 reference

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1310%2FHCT1506-269

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, d

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1506-269

Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1506-269

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1506-269

A new equation to estimate glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1506-269

Current status and future perspectives for CKD testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1506-269

21 January 2018

Identifiers

DOI

10.1310/HCT1506-269

1 reference

6 October 2017

1 reference